Aarhus University
Aarhus University is recorded as a service provider in 20 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 20 of 20 trials · Latest update first
A study in healthy volunteers to improve methods for detection of GHB in drug rape victims
Sponsor Aarhus University
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available2 trial-level findings · Read insights
- Between November 2022 and June 2023, 42 individuals were assessed, with 2 excluded and 10 withdrawing before randomization; 30 participants completed the trial between December 2022 and July 2023.
- Recruitment used social media, the Danish trial-recruitment website forskningnu.dk, and posters at Aarhus University Hospital and nearby higher educational institutions.
These findings describe the trial, not the service provider’s performance or responsibility.
The Optimised use of Romosozumab Study
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Intraoperative clonidine for postoperative pain management in patients undergoing spine surgery: a prospective, randomized, blinded, placebo-controlled trial
Sponsor Aarhus Universitetshospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available5 trial-level findings · Read insights
- Enrollment and trial conduct occurred only in Denmark at Aarhus University Hospital.
- Lower-than-expected morphine consumption in the placebo group meant that the anticipated 10 mg reduction in IV morphine consumption could not be detected.
- Pain intensity or patient satisfaction was not used as the primary patient-reported outcome.
- A patient-controlled analgesia device could have provided a more precise measure of opioid requirement.
- Bradycardia and hypotension were not confined to the clonidine group, making unblinding unlikely.
These findings describe the trial, not the service provider’s performance or responsibility.
Perioperative treatment with Tranexamic Acid (TXA) in melanoma; prognostic and treatment related impact of the plasminogen-plasmin pathway
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy: a double-blind, multicenter, placebo-controlled, international phase II clinical trial
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
Treatment with zoledronate subsequent to denosumab in osteoporosis 2
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Safety of ibuprofen after major orthopaedic surgeries - the PERISAFE randomized clinical multicentre trial
Sponsor Slagelse Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
The effect of the Popliteal Plexus Block on the motor function of the leg - a randomized, controlled, blinded study in volunteers
Sponsor Region Midtjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial
Sponsor Odense University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Insulin Resistance and Statin Treatment in Renal Transplant Recipients and Patients with Chronic Kidney Disease
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
AN INVESTIGATOR-INITIATED, PHASE 4, OPEN-LABEL, SINGLE-ARM, SINGLE-CENTER STUDY INVESTIGATING THE TISSUE-RESIDENT MEMORY T-CELLS AND DISEASE MEMORY IN PSORIASIS SKIN DURING GUSELKUMAB TREATMENT. THE GUSMEM STUDY.
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Plethysmography with acetylcholin and carbacholin – A clinical method study
Sponsor Regionshospitalet Godstrup
- Start (EU)
- Latest update
- Estimated end
- Not reported
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren Contracture Affecting the Metacarpophalangeal Joint. A Randomized Controlled Trial.
Sponsor Region Midtjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Nordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial
Sponsor Region Midtjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Infliximab for non-Crohn Anal Fistulas
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Sponsor Aarhus University
- Start (EU)
- Latest update
- Estimated end
- Not reported
The effect of fremanezumab on pain in patients with Complex Regional Pain Syndrome: a randomized, double-blind, proof of concept, placebo-controlled trial
Sponsor Aarhus University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
Sponsor Aarhus University
- Start (EU)
- Latest update
- Estimated end
- Not reported
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial
Sponsor Region Midtjylland
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Aarhus University?
The 2026-10-09 snapshot links Aarhus University to 20 distinct CTIS trials. Recorded services include Clinical monitoring, Quality assurance & auditing, Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Aarhus University?
The most frequently recorded therapeutic areas are Musculoskeletal, Endocrinology, Other. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Aarhus University conducted?
The linked trials record locations in 3 countries, including Denmark, Iceland, Sweden. These are trial locations, not confirmed office locations or countries where Aarhus University delivered services.
What can this page tell me about Aarhus University's trial experience?
Browse 20 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 2 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Aarhus University. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Aarhus University